GlobeNewswire Inc | Sep 27, 2021 07:00AM EDT

September 27, 2021

VANCOUVER, British Columbia, Sept. 27, 2021 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler and children nutrition company, announces that it has developed a wide range of Canada-compliant products, set to launch in Q1 2022. The product range will include baby cereals for 6+ months, a toddler nutrition product, and a line of Childrens complete nutrition products. The Canada-compliant offerings are slated to launch online on Elses e-store, as well as other Canadian online retailers and brick and mortar chains.

This is a major milestone for the Company. We are responding to the tremendous demand for Else products by Canadians since the beginning, and weve seen rapid double-digit monthly growth in Canada on the online iHerb platform, said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. Having a dedicated range of products for Canada, making our complete whole food-based solutions more accessible to millions of wanting Canadian families, will open up a pathway for further growth in this high potential market, she added.

Else Plant-Based Complete Nutrition for Toddlers, which is currently available to Canadians through iHerb, more than doubled its unit sales on the platform this summer. The Canadian Baby Food Market has been experiencing strong growth, reaching almost CAD $700 million in 2020.

About Else Nutrition Holdings Inc.

Else Nutrition GH Ltd. is an Israel-based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at the Global Food Innovation Summit in Milan. Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else'sExecutives include leaders hailing fromleading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children's Hospital, Pediatrics at Harvard Medical School, USA, Tel Aviv University, Schneider Children's Medical Center of Israel, Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium.

For more information, visit:elsenutrition.comor @elsenutrition on Facebook and Instagram.

Media ContactErin JundefBrilliant PRErinj@brilliantprm.com

For more information, contact:Mrs. Hamutal Yitzhak, CEO, Co-Founder & DirectorELSE Nutrition Holdings Inc.E: hamutaly@elsenutrition.comP: +972(0)3-6445095

Mr. Sokhie Puar, Lead Director of Else NutritionEmail:sokhiep@elsenutrition.comP: 604-603-7787

TSX Venture Exchange

Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward-Looking Statements

This press release contains statements that may constitute forward-looking statements within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as will or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the Companys financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs and assumptions, which are based on managements perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker and supply logistic agreement with the Company do not terminate. Actual results may differ from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect managements expectations only as of the date of this press release. The Company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.